UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Synergistic and additive interactions of the cannabinoid agonist CP55,940 with μ opioid receptor and α 2 ‐adrenoceptor agonists in acute pain models in mice

British journal of pharmacology, 2009-01, Vol.144 (6), p.875-884

2009

Volltextzugriff (PDF)

Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Δ9-THC)

Psychopharmacology, 2022-05, Vol.239 (5), p.1289-1309

2022

Volltextzugriff (PDF)

Effects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in mice

Drug and alcohol dependence, 2015-05, Vol.150, p.31-37

2015

Volltextzugriff (PDF)

Involvement of the infralimbic cortex and CA1 hippocampal area in reconsolidation of a contextual fear memory through CB1 receptors: Effects of CP55,940

Neurobiology of learning and memory, 2016-01, Vol.127, p.42-47

2016

Volltextzugriff (PDF)

Cannabinoid effects on CB1 receptor density in the adolescent brain: An autoradiographic study using the synthetic cannabinoid HU210

Synapse (New York, N.Y.), 2010-11, Vol.64 (11), p.845-854

2010

Volltextzugriff (PDF)

Protective Effects of the Synthetic Cannabinoids CP55,940 and JWH-015 on Rat Brain Mitochondria upon Paraquat Exposure

Neurochemical research, 2010-09, Vol.35 (9), p.1323-1332

2010

Volltextzugriff (PDF)

Long-lasting increase in [3 H]CP55,940 binding to CB1 receptors following cocaine self-administration and its withdrawal in rats

Brain research, 2012-04, Vol.1451, p.34-43

2012

Volltextzugriff (PDF)

CP55,940 attenuates spatial memory retrieval in mice

Pharmacological reports, 2014-12, Vol.66 (6), p.931-936

2014

Volltextzugriff (PDF)

Acute cannabinoid administration attenuates female socio-sexual motivation

Pharmacology, biochemistry and behavior, 2010, Vol.94 (3), p.482-487

2010

Volltextzugriff (PDF)

Molecular Basis of Cannabis-Induced Schizophrenia-Relevant Behaviours: Insights from Animal Models

Current behavioral neuroscience reports, 2017-09, Vol.4 (3), p.254-279

2017

Volltextzugriff (PDF)

Residual effects of focal brain ischaemia upon cannabinoid CB1 receptor density and functionality in female rats

Brain research, 2011-02, Vol.1373, p.195-201

2011

Volltextzugriff (PDF)

Receptor mechanism and antiemetic activity of structurally‐diverse cannabinoids against radiation‐induced emesis in the least shrew

European journal of pharmacology, 2007-06, Vol.563 (1), p.187-196

2007

Volltextzugriff (PDF)

Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys

Neuropharmacology, 2011-02, Vol.60 (2-3), p.418-422

2011

Volltextzugriff (PDF)

Agmatine enhances cannabinoid action in the hot-plate assay of thermal nociception

Pharmacology, biochemistry and behavior, 2009-10, Vol.93 (4), p.426-432

2009

Volltextzugriff (PDF)

In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors

Journal of neuroimmunology, 2000-09, Vol.109 (2), p.155-163

2000

Volltextzugriff (PDF)

Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids

Critical reviews in neurobiology, 2003, Vol.15 (2), p.91-119

Sim-Selley, Laura J

2003

Volltextzugriff (PDF)

Virodhamine and CP55,940 modulate cAMP production and IL‐8 release in human bronchial epithelial cells

British journal of pharmacology, 2007-08, Vol.151 (7), p.1041-1048

2007

Volltextzugriff (PDF)

Changes in the Cannabinoid Receptor Binding, G Protein Coupling, and Cyclic AMP Cascade in the CNS of Rats Tolerant to and Dependent on the Synthetic Cannabinoid Compound CP55,940

Journal of neurochemistry, 2000-11, Vol.75 (5), p.2080-2086

2000

Volltextzugriff (PDF)

Topically administered CB 2-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits

Life sciences (1973), 2003, Vol.72 (7), p.837-842

2003

Volltextzugriff (PDF)

Effects of the cannabinoid CB1 receptor agonist CP55,940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebus monkeys

Journal of psychopharmacology (Oxford), 2006-09, Vol.20 (5), p.622-628

2006

Volltextzugriff (PDF)

Topically administered CB2-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits

Life sciences (1973), 2003-01, Vol.72 (7), p.837-842

2003

Volltextzugriff (PDF)

Cannabinoids enhance human B-cell growth at low nanomolar concentrations

FEBS letters, 1995-08, Vol.369 (2), p.177-182

1995

Volltextzugriff (PDF)

Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception

European journal of pharmacology, 1999-08, Vol.378 (3), p.237-248

1999

Volltextzugriff (PDF)

Synergistic and additive interactions of the cannabinoid agonist CP55,940 with μ opioid receptor and α2‐adrenoceptor agonists in acute pain models in mice

British journal of pharmacology, 2005-03, Vol.144 (6), p.875-884

2005

Volltextzugriff (PDF)

Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation

European journal of pharmacology, 2003-01, Vol.459 (1), p.83-95

2003

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Synergistic and additive interactions of the cannabinoid agonist CP55,940 with μ opioid receptor and α 2 ‐adrenoceptor agonists in acute pain models in mice

Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Δ9-THC)

Effects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in mice

Involvement of the infralimbic cortex and CA1 hippocampal area in reconsolidation of a contextual fear memory through CB1 receptors: Effects of CP55,940

Cannabinoid effects on CB1 receptor density in the adolescent brain: An autoradiographic study using the synthetic cannabinoid HU210

Protective Effects of the Synthetic Cannabinoids CP55,940 and JWH-015 on Rat Brain Mitochondria upon Paraquat Exposure

Long-lasting increase in [3 H]CP55,940 binding to CB1 receptors following cocaine self-administration and its withdrawal in rats

CP55,940 attenuates spatial memory retrieval in mice

Acute cannabinoid administration attenuates female socio-sexual motivation

Molecular Basis of Cannabis-Induced Schizophrenia-Relevant Behaviours: Insights from Animal Models

Residual effects of focal brain ischaemia upon cannabinoid CB1 receptor density and functionality in female rats

Receptor mechanism and antiemetic activity of structurally‐diverse cannabinoids against radiation‐induced emesis in the least shrew

Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys

Agmatine enhances cannabinoid action in the hot-plate assay of thermal nociception

In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors

Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids

Virodhamine and CP55,940 modulate cAMP production and IL‐8 release in human bronchial epithelial cells

Changes in the Cannabinoid Receptor Binding, G Protein Coupling, and Cyclic AMP Cascade in the CNS of Rats Tolerant to and Dependent on the Synthetic Cannabinoid Compound CP55,940

Topically administered CB 2-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits

Effects of the cannabinoid CB1 receptor agonist CP55,940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebus monkeys

Topically administered CB2-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits

Cannabinoids enhance human B-cell growth at low nanomolar concentrations

Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception

Synergistic and additive interactions of the cannabinoid agonist CP55,940 with μ opioid receptor and α2‐adrenoceptor agonists in acute pain models in mice

Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation

Suchergebnisse filtern